Skip to main content
L

LIWANLI Innovation Co., Ltd. — Investor Relations & Filings

Ticker · 3054 TW Wholesale and retail trade
Open in API
Filings indexed 1,628 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country TW Taiwan
Listing TW 3054

About LIWANLI Innovation Co., Ltd.

https://www.liwanli.com.tw

Liwanli Innovation Co., Ltd. is a technology-driven enterprise that transitioned from its origins in mobile multimedia and storage solutions into the biotechnology and healthcare sectors. Originally established in 1991, the company underwent a strategic rebranding in 2015 to focus on the research, development, and distribution of health supplements and nutritional products. Its core operations involve the creation of patented formulas and the application of innovative R&D techniques to meet consumer wellness needs. The company leverages extensive industry-university collaborations and maintains advanced laboratory facilities to ensure the scientific integrity of its product offerings. In addition to its primary focus on biotechnology and health products, the company continues to engage in the sale of electronic components and consumer electronics, emphasizing a philosophy of precision and nutritional excellence.

Recent filings

Filing Released Lang Actions
115年年報及股東會資料 — 2026_3054_20260527F01.pdf
Regulatory Filings
2026-04-24 Chinese
115年年報及股東會資料 — 2026_3054_20260527FE2.pdf
AGM Information Classification · 1% confidence The document is the “2026 Annual General Shareholders’ Meeting Meeting Handbook (Translation)” for Liwanli Innovation Co., Ltd. It contains the agenda, meeting procedures, proposed resolutions (reported matters, ratification items, discussions, election matters, etc.), and attachments (business report, audit committee review, financial statements, director remuneration, etc.) for the Annual General Meeting. This is clearly shareholder meeting materials rather than an earnings release, report announcement, or other regulatory filing. Therefore, it should be classified as AGM Information (AGM-R).
2026-04-24 English
115年年報及股東會資料 — 2026_3054_20260527F02.pdf
Regulatory Filings
2026-04-24 Chinese
本公司將於115/04/27召開董事會通過115年第一季財務報告
Report Publication Announcement Classification · 1% confidence The document is a notice from a listed company on the public information observatory stating that the board meeting will be convened on 115/04/27 to approve the first quarter financial report. It does not contain the financial data itself but announces the timing of the report’s approval and publication. This fits the definition of a Report Publication Announcement (RPA).
2026-04-17 Chinese
公告本公司董事會決議辦理私募有價證券案
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory announcement by a listed company’s board of directors detailing the resolution to conduct a private placement of new securities (ordinary shares or convertible bonds), including issuance limits, pricing mechanisms, and capital usage. This is an announcement of a new share issue/capital change rather than an earnings release, management discussion, or AGM materials. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-04-09 Chinese
公告本公司董事會決議通過114年下半年度盈餘分派現金股利案
Notice of Dividend Amount Classification · 1% confidence The document is a regulatory disclosure by a listed company announcing the board of directors’ resolution to distribute a cash dividend for the second half of fiscal year 114, including per-share amounts and total payout. This fits the description of a Notice of Dividend Amount (Code: DIV).
2026-04-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.